Financials

  • Market Capitalization 17.54 M
  • Employee 5
  • Founded 2004
  • CEO N/A
  • Website www.akaritx.com
  • Headquarter United Kingdom
  • FIGI BBG003PMV495
  • Industry Biotechnology
Total revenue
Net income
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
Price to sales ratio
-6 348.39

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4613
RADX
Radiopharm Theranostics Limited American Depositary Shares
2.26 USD-2.59%-4.24%-26.86%-60.63%17.82 M USD
4614
BCDA
BioCardia, Inc. - Common Stock
1.17 USD-1.68%+20.62%+48.10%+1.30%17.71 M USD
4637
CTXR
Citius Pharmaceuticals, Inc. - Common Stock
0.61 USD+5.17%0.00%+22.00%-60.39%16.75 M USD
4641
BIVI
BioVie Inc. - Common stock
2.19 USD+3.79%+1.39%+63.43%+73.81%16.52 M USD

Frequently asked questions about Akari Therapeutics plc ADR (0.01 USD)

What is the Akari Therapeutics plc ADR (0.01 USD) stock price today?

The current price of Akari Therapeutics plc ADR (0.01 USD) (AKTX) is 9.01. Over the past 24 hours, the stock has changed by -0.99%. Follow the AKTX chart for real-time price dynamics.

What is the stock ticker of Akari Therapeutics plc ADR (0.01 USD)?

Akari Therapeutics plc ADR (0.01 USD) trades under the ticker AKTX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Akari Therapeutics plc ADR (0.01 USD) stock going up?

AKTX has changed by +11.23% over the last week, +10.55% over the last month, and +1012.35% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Akari Therapeutics plc ADR (0.01 USD)?

Akari Therapeutics plc ADR (0.01 USD) currently has a market capitalization of 17.54 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Akari Therapeutics plc ADR (0.01 USD) earnings last quarter?

Last quarter, Akari Therapeutics plc ADR (0.01 USD) reported earnings of 0 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Akari Therapeutics plc ADR (0.01 USD) revenue for the last quarter?

Akari Therapeutics plc ADR (0.01 USD) reported quarterly revenue of -63 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Akari Therapeutics plc ADR (0.01 USD) net income for the last quarter?

Akari Therapeutics plc ADR (0.01 USD) reported net income of -4.81 M for the last quarter. The previous quarter showed -14.46 M, which means net income changed by +66.75%.

How many employees does Akari Therapeutics plc ADR (0.01 USD) have?

As of the latest available data, Akari Therapeutics plc ADR (0.01 USD) has 5 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Akari Therapeutics plc ADR (0.01 USD) stock?

You can buy Akari Therapeutics plc ADR (0.01 USD) (AKTX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Akari Therapeutics plc ADR (0.01 USD) stock?

Investing in Akari Therapeutics plc ADR (0.01 USD) requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the AKTX chart and related analysis on metatrader.com as part of your research.

News